000 | 01888 a2200529 4500 | ||
---|---|---|---|
005 | 20250513150420.0 | ||
264 | 0 | _c19981029 | |
008 | 199810s 0 0 eng d | ||
022 | _a0306-4522 | ||
024 | 7 |
_a10.1016/s0306-4522(98)00094-3 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aKhateb, A | |
245 | 0 | 0 |
_aGABAergic input to cholinergic nucleus basalis neurons. _h[electronic resource] |
260 |
_bNeuroscience _cOct 1998 |
||
300 |
_a937-47 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 |
_a2-Amino-5-phosphonovalerate _xpharmacology |
650 | 0 | 4 |
_a6-Cyano-7-nitroquinoxaline-2,3-dione _xpharmacology |
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 |
_aBaclofen _xpharmacology |
650 | 0 | 4 |
_aBicuculline _xpharmacology |
650 | 0 | 4 |
_aCholine O-Acetyltransferase _xmetabolism |
650 | 0 | 4 |
_aExcitatory Postsynaptic Potentials _xdrug effects |
650 | 0 | 4 | _aGABA-A Receptor Agonists |
650 | 0 | 4 | _aGABA-A Receptor Antagonists |
650 | 0 | 4 | _aGABA-B Receptor Agonists |
650 | 0 | 4 | _aGABA-B Receptor Antagonists |
650 | 0 | 4 |
_aGlutamate Decarboxylase _xmetabolism |
650 | 0 | 4 | _aGuinea Pigs |
650 | 0 | 4 | _aImmunohistochemistry |
650 | 0 | 4 | _aIn Vitro Techniques |
650 | 0 | 4 |
_aMuscimol _xpharmacology |
650 | 0 | 4 |
_aNeurons _xdrug effects |
650 | 0 | 4 |
_aProsencephalon _xdrug effects |
650 | 0 | 4 |
_aReceptors, GABA-A _xphysiology |
650 | 0 | 4 |
_aReceptors, GABA-B _xphysiology |
650 | 0 | 4 |
_aSubstantia Innominata _xphysiology |
650 | 0 | 4 |
_aSynaptic Transmission _xdrug effects |
650 | 0 | 4 |
_agamma-Aminobutyric Acid _xpharmacology |
700 | 1 | _aFort, P | |
700 | 1 | _aWilliams, S | |
700 | 1 | _aSerafin, M | |
700 | 1 | _aMühlethaler, M | |
700 | 1 | _aJones, B E | |
773 | 0 |
_tNeuroscience _gvol. 86 _gno. 3 _gp. 937-47 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1016/s0306-4522(98)00094-3 _zAvailable from publisher's website |
999 |
_c9658383 _d9658383 |